Abstract:Background: Cardiomyopathy is known to be a heterogeneous disease with numerous etiologies. They all have varying degrees and types of myocardial pathological changes, resulting in impaired contractility, ventricle relaxation, and heart failure. The purpose of this study was to determine the pathogenesis, immune-related pathways and important biomarkers engaged in the progression of cardiomyopathy from various etiologies. Methods: We downloaded the gene microarray data from the Gene Expression Omnibus (GEO). The hub genes between cardiomyopathy and non-cardiomyopathy control groups were identified using differential expression analysis, least absolute shrinkage and selection operator (LASSO) regression and weighted gene co-expression network analysis (WGCNA). To assess the diagnostic precision of hub genes, receiver-operating characteristic (ROC) curves as well as the area under the ROC curve (AUC) were utilized. Then, Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment pathway analysis and Gene Ontology (GO) analysis were conducted on the obtained differential genes. Finally, single-sample GSEA (ssGSEA) and Gene Set Enrichment Analysis (GSEA) were utilized to analyze the infiltration level of 28 immune cells and their relationship with hub genes based on gene expression profile data and all differential gene files. Results: A total of 82 differentially expressed genes (DEGs) were screened after the training datasets were merged and intersected. The WGCNA analysis clustered the expression profile data into four co-expression modules, The turquoise module exhibited the strongest relationship with clinical traits, and nine candidate key genes were obtained from the module. Then we intersected DEGs with nine candidate genes. LASSO regression analysis identified the last three hub genes as promising biomarkers to distinguish the cardiomyopathy group from the non-cardiomyopathy control group. ROC curve analysis in the validation dataset revealed the sensitivity and accuracy of three hub genes as marker genes. The majority of the functional enrichment analysis results were concentrated on immunological and inflammatory pathways. Immune infiltration analysis revealed a significant correlation between regulatory T cells, type I helper T cells, macrophages, myeloid-derived suppressor cells, natural killer cells, activated dendritic cells and the abundance of immune infiltration in hub genes. Conclusion: The hub genes (CD14, CCL2, and SERPINA3) can be used as markers to distinguish cardiomyopathy from non-cardiomyopathy individuals. Among them, SERPINA3 has the best diagnostic performance. T cell immunity (adaptive immune response) is closely linked to cardiomyopathy progression. Hub genes may protect the myocardium from injury through myeloid-derived suppressor cells, regulatory T cells, helper T cells, monocytes/macrophages, natural killer cells and activated dendritic cells. The innate immune response is crucial to this process. Dysregulation and imbalance of innate immune cells or activation of adaptive immune responses are involved in cardiomyopathy disease progression in patients.

Arrhythmia and cardiomyopathy related chemokine networks: A review of their development

The Role of CXC Chemokines in Cardiovascular Diseases

Analysis of Changes in Circular RNA Expression and Construction of Cerna Networks in Human Dilated Cardiomyopathy.

Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression

Mechanistic and Therapeutic Perspectives for Cardiac Arrhythmias: Beyond Ion Channels

Relevance of the chemokine CXCL12/CXCR7 axis in cardiovascular disease

Inflammatory Cytokines and Cardiac Remodelling of Postmyocardial Infarction

Advances in the Study on Chemokines and Chemokine Receptor Antagonists

The roles and mechanisms of epigenetic regulation in pathological myocardial remodeling

The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?

The relationship between chemokines expression and the cardiac function after acute myocardial infarction in rats

CKLF1 in cardiovascular and cerebrovascular diseases

Inherited Arrhythmias Cardiomyopathies: 2007 Advancement and Workshop Consensus

Chemokines, Chemokine Receptors and Hematopoiesis

Potential Role of CC Chemokines and Their Receptors in the Development of Respiratory Diseases

The Potential Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Cardiovascular System, Respiratory System and Skin

Endothelin-NADPH Oxidase Pathway and Calcium Regulatory Proteins in Myocardium:New Targets for the Treatment of Cardiac Arrhythmias and Heart Failure

Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease

Cardiac arrhythmogenesis: roles of ion channels and their functional modification

Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential

Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer